Mark Radzyner
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Surgical Treatments
-
- Gastric Cancer Management and Outcomes
- Gallbladder and Bile Duct Disorders
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 5
- Economic and Financial Impacts of Cancer 4
- Oncology 4
- Colorectal Cancer Surgical Treatments 2
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- David M. Rubin (10 shared papers)Murray F. Brennan (3 shared papers)James Dougherty (1 shared paper)Edward L. Hannan (1 shared paper)Yuman Fong (1 shared paper)Mithat Gönen (1 shared paper)David G. Pfister (4 shared papers)Peter B. Bach (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer (2 papers)JAMA Oncology (1 paper)Journal of Surgical Oncology (1 paper)Surgery (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Mark Radzyner
13 papers receiving 794 citations
Peers
Comparison fields: 5 of 79
- Oncology 458
- Pulmonary and Respiratory Medicine 332
- Surgery 349
- Hepatology 58
- Gastroenterology 28
Countries citing papers authored by Mark Radzyner
This map shows the geographic impact of Mark Radzyner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Radzyner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Radzyner more than expected).
Fields of papers citing papers by Mark Radzyner
This network shows the impact of papers produced by Mark Radzyner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Radzyner. The network helps show where Mark Radzyner may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Radzyner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 315 | |
| 2 | 2005 | 303 | |
| 3 | 2015 | 93 | |
| 4 | 1983 | 35 | |
| 5 | 2001 | 29 | |
| 6 | 2009 | 18 | |
| 7 | Effects of glucagon, vasoactive intestinal peptide (VIP) and lysine-vasopressine on villous microcirculation and superior mesenteric artery blood flow of the rat. | 1979 | 6 |
| 8 | 2019 | 4 | |
| 9 | 2004 | 3 | |
| 10 | 2001 | 1 | |
| 11 | 1994 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2018 | 1 |
About Mark Radzyner
Mark Radzyner is a scholar working on Economics and Econometrics, Oncology, Pulmonary and Respiratory Medicine, Cellular and Molecular Neuroscience and Epidemiology, having authored 13 papers that have together received 810 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Economic and Financial Impacts of Cancer (4 papers), Colorectal Cancer Surgical Treatments (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Neuropeptides and Animal Physiology (2 papers), Gastric Cancer Management and Outcomes (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Cystic Fibrosis Research Advances (1 paper). The work is most often cited by research in Oncology (458 citations), Pulmonary and Respiratory Medicine (332 citations), Surgery (349 citations), Hepatology (58 citations) and Gastroenterology (28 citations). Mark Radzyner has collaborated with scholars based in United States and Switzerland. Frequent co-authors include David M. Rubin, Murray F. Brennan, James Dougherty, Edward L. Hannan, Yuman Fong, Mithat Gönen, David G. Pfister, Peter B. Bach, Ushma S. Neill and Elena B. Elkin. Their work appears in journals such as Journal of Clinical Oncology, Cancer, JAMA Oncology, Journal of Surgical Oncology and Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.